key: cord-0951030-7lcxy2ky authors: Opel, Douglas J.; Lo, Bernard; Peek, Monica E. title: Addressing Mistrust About COVID-19 Vaccines Among Patients of Color date: 2021-02-09 journal: Ann Intern Med DOI: 10.7326/m21-0055 sha: 40338d6b84c2da99dbf55f1c561f88bbd3f8dfef doc_id: 951030 cord_uid: 7lcxy2ky This commentary suggests specific strategies and language that clinicians can use to address mistrust of COVID-19 vaccines among racial and ethnic minorities. Four specific communication strategies may help promote trust among patients of color about COVID-19 vaccines. First, lead with listening. Patients, particularly those from marginalized communities, desire health care interactions in which their experiences are heard and validated. Consider beginning the COVID-19 vaccine conversation with an open-ended invitation for the patient to share their perspective, such as "You may be hearing a lot about COVID vaccines. Tell me what you think about them." Doing so can also help avoid erroneous assumptions about a patient's self-identity or experience. This approach differs from standard vaccine communication practices for well-established and routinely recommended vaccines. For these vaccines, starting the conversation with the implicit assumption that vaccination will happen, such as "You're due for your tetanus booster today," has been associated with increased vaccine uptake. For COVID-19 vaccines, however, which have, to date, been made available only through an emergency use authorization, a more appropriate approach is to facilitate shared decision making. Second, tailor responses to patient concerns. If patients respond to an invitation to share their perspective about COVID-19 vaccines either equivocally (such as "I'm not sure.") or negatively (such as "Those vaccines aren't for me."), do not provide reassurance prematurely. Doing so may be ineffective if it is done before listening to and exploring the patient's concerns in detail. Rather, engage with the patient nonjudgmentally and collaboratively. Motivational interviewing (MI) techniques can facilitate this engagement (6) (Table, top) and have been found to be effective in improving vaccine uptake among those who voice reluctance (7) . These techniques can also be used to explore and address COVID-19 vaccine concerns rooted in structural injustice (Table, bottom), complementing other suggested COVID-19 communication approaches (8) . Of importance, a clinician's vaccine recommendation, a factor associated with increased uptake (9), can be integrated with MI. For instance, consider asking permission to make a recommendation and, if granted, stating, "In my view, the benefits of COVID-19 vaccination outweigh the risks. I am strongly recommending these vaccines to my patients." Third, briefly describe the regulatory and development processes surrounding COVID-19 vaccines using accessible language. There may be confusion about, and negative connotations with, terms used to describe the vaccine regulatory process (10) . The term "emergency use authorization," for instance, may lead to misunderstanding or exacerbate mistrust. Patients may believe that a new vaccine, for instance, has been authorized "emergently" before any data could be reviewed, This article was published at Annals.org on 9 February 2021. Annals of Internal Medicine © 2021 American College of Physicians 1 harkening back to days of experimentation on enslaved people, indigenous people, prisoners, immigrants, and unknowing Black Americans. Consider simple factual statements that avoid confusing terminology, such as "The FDA has authorized these vaccines now after reviewing a lot of evidence carefully" (see also bottom part of the Table) . Lastly, acknowledge uncertainty. The shortage of COVID-19 vaccines is unprecedented, and delivery schedules are changeable. There is much not yet known about COVID-19 vaccines, particularly regarding their long-term safety, their effect on transmission of severe acute respiratory syndrome coronavirus 2, and their efficacy against new strains. Acknowledging uncertainty creates transparency, and transparency is key to facilitating trust during public health emergencies. COVID-19 vaccines are not routine vaccines, nor are these routine circumstances. This past year has laid bare harsh health disparities and structural injustice in the United States, activating and exacerbating mistrust among people of color. Clinicians need to address this mistrust to help patients at highest risk for COVID-19 gain the benefits of COVID-19 vaccines. Prioritizing these discussions now in routine clinic visits, even over other health maintenance or stable chronic disease management issues, may help increase the acceptance of COVID-19 vaccinations and improve health outcomes among persons of color. Statements that support patient autonomy Enhances a patient's sense of control and helps them feel more at ease with the conversation "I want you to know that this is your decision to make." Rolling with resistance Meeting patient resistance with curiosity (an opportunity to understand more about the patient's perspective in a nonjudgmental, respectful way) rather than confrontation encourages continued patient engagement "I am hearing that you don't think you'll get the COVID vaccine anytime soon. Tell me more about what is concerning you." Concern Example Response I am really worried I'll get sick after the vaccine and won't be able to go to work. "You want to make sure that if you get vaccinated, it won't impact your ability to work. That makes sense." After listening and further exploring the patient's concerns, consider: "It's true that some people will experience side effects. These side effects are similar to those from other vaccines-muscle aches, fever, and soreness at the injection site. You might want to get vaccinated before having a few days off." Why should I trust the government since people like me have been guinea pigs for testing in the past? "I understand why you have a lot of mistrust. The government and research systems have not always treated your community fairly." After listening and further exploring the patient's concerns, consider: "There are now people of color leading and working in research studies to make sure their communities are protected from harm, yet have equal access to the benefits of scientific discovery. Would it be OK if I shared my medical perspective on how COVID vaccines were tested?" I just hear a lot of talk about how the vaccine will give people COVID. "You are not the only one with those concerns. There is a lot of information out there on COVID and the vaccine, and it is hard to know what is true and what is false." After listening and further exploring the patient's concerns, consider: "This is one of those false pieces of information. You cannot get COVID from the vaccine. Can I tell you about how about the COVID vaccine works?" I hear if you get the vaccine you can get deported. "What a frightening thing to hear. Can you tell me more about what you heard?" After listening and further exploring the patient's concerns, consider: "I want to assure you that no information about immigration status is collected when you get vaccinated. It is important that everyone who needs this vaccine is able to get it." It scares me that the military is giving the vaccine. "I can understand how that sounds scary." After listening and further exploring the patient's concerns, consider: "The military is only helping to make sure the vaccine gets delivered to all parts of the country. No soldiers will be giving the vaccine. Only doctors, nurses, and health care workers are giving the vaccine." Addressing Mistrust About COVID-19 Vaccines Among Patients of Color Centers for Disease Control and Prevention. Talking to recipients about COVID-19 vaccines Coronavirus Vaccine Hesitancyin Black and Latinx Communities Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases KFF COVID-19 vaccine monitor Comparison of knowledge and information-seeking behavior after general COVID-19 public health messages and messages tailored for black and latinx communities: a randomized controlled trial Motivational Interviewing: Preparing People for Change Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: A cluster randomized clinical trial National Vaccine Advisory Committee. Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice Public understanding of medical countermeasures Ninth Avenue, M/S: JMB-6 University of California San Francisco School of Medicine, 1701 Divisidero Street, Fifth Floor Peek: 5841 South Maryland Avenue Critical revision for important intellectual content